Partner With Cellular Life Solutions
High-quality human starter cells serve as the foundation for many experiments and can have a substantial influence on downstream applications. Cellular Life Solutions is a leading provider of high-quality human cellular starting material, with services distributing worldwide.
Highest Quality Control Standards
Cellular Life Solutions delivers excellent-quality goods and services to scientists and physicians nationwide, continually enhancing processes to meet client expectations and regulatory standards. By partnering with industry leaders, we ensure all products meet strict quality control standards before reaching our clients, supporting cell therapies that help improve patient health.
Clients can customize cell orders and collection criteria, ensuring their research and product development are optimized to the highest standards. Whether you need specific donor recruitment, pre-screening, recallable donors, or specialized packaging and shipping, Cellular Life Solutions offers unparalleled flexibility. Through use of our industry-leading apheresis donor pool, we can consistently provide high-quality, rigorously screened biological materials.
With over 40 years of biomedical expertise and targeted donor outreach, we ensure that every project gains a significant advantage through our extensive, recallable donor network and tailored solutions. We are accredited by several institutions for our cellular therapy services, including the Foundation for the Accreditation of Cell Therapy (FACT), the Association for the Advancement of Blood & Biotherapies (AABB), and the FDA.
Cell and Gene Therapy Products:
A leukopak is an enriched leukapheresis product with a high concentration of white blood cells (monocytes and lymphocytes) and platelets suspended in donor plasma, with a hematocrit of <4%. The final product volume is 180-200mL.
Leukopaks or mononuclear cells (MNCs) are collected under IRB-approved protocols.
Source: Leukopaks are collected at our licensed leukapheresis centers located in Houston, Texas.
Format: Fresh non-mobilized leukopaks.
Donors Criteria: Donors have an approved consent for donating leukocytes. All donors are screened to ensure that each is in good health and meet specific eligibility criteria.
Testing: In addition to ABO/Rh and testing for atypical or unusual red cell antibodies, donors are also tested for hepatitis B (HBsAg, anti-HBc, HBV NAT) and C (anti-HCV, HCV NAT), HIV (anti-HIV 1,2, HIV NAT), HTLV-I/II, syphilis, West Nile virus, and Trypanosoma cruzi (anti-T. cruzi). Testing for hemoglobin S carriers, CMV antibodies, and HLA antibodies is performed on selected donors.
Buffy coat products obtained from whole blood are rich in white blood cells and platelets. Buffy coats are a useful source of cells for in vitro study. Because of the variability of white blood cell populations in buffy coat products, further processing and characterization are usually necessary.
Source: The whole blood is collected at one of our 17 licensed U.S. blood centers or at one of our blood drives. Whole blood is further processed in our processing centers to produce the buffy coats.
Donors Criteria: Donors have an approved consent for donating blood. All donors are screened to ensure that each is in good health and that products are not collected from a high-risk population for blood-borne infections.
Testing:In addition to ABO/Rh and testing for atypical or unusual red cell antibodies, donors are also tested for hepatitis B (HBsAg, anti-HBc, HBV NAT) and C (anti-HCV, HCV NAT), HIV (anti-HIV 1,2, HIV NAT), HTLV-I/II, syphilis, West Nile virus, and Trypanosoma cruzi (anti-T. cruzi). Testing for hemoglobin S carriers, CMV antibodies, and HLA antibodies is performed on selected donors.
Peripheral blood stem cell (PBSC) donation is one method of harvesting stem cells for transplant. This is performed by an apheresis process in an outpatient setting.
The donation process takes between 4-8 hours. In order to collect sufficient numbers of stem cells, donors receive filgrastim or an analog in the 5 days prior to the collection procedure. All donors must receive the prescription for filgrastim from the ordering physician, as Gulf Coast Regional Blood Center does not provide stimulated donors.
Autologous: The stem cells in autologous transplants come from the same person who will get the transplant, so the patient is their own donor.
Allogeneic: The stem cells in allogeneic transplants are from a person other than the patient, either a matched related or unrelated donor.
Source: PBSCs are collected at our licensed centers located in Houston, Texas.
Donors Criteria: Donors have an approved consent for donating stem cells and typically receive a CD34+ stimulating agent for 5 days prior to the collection. All donors are screened to ensure that each of them is in good health condition and that products are not collected from a high-risk population for blood-borne infections.
Testing: In addition to ABO/Rh and testing for atypical or unusual red cell antibodies, donors are also tested for hepatitis B (HBsAg, anti-HBc, HBV NAT) and C (anti-HCV, HCV NAT), HIV (anti-HIV 1,2, HIV NAT), HTLV-I/II, syphilis, West Nile virus, and Trypanosoma cruzi (anti-T. cruzi). Testing for hemoglobin S carriers, CMV antibodies, and HLA antibodies is performed on selected donors.
Advanced Collection Technology
At Cellular Life Solutions, groundbreaking research in cell-based immunotherapy is paving the way for new treatments for illnesses.
The core of our operation is the Spectra Optia Apheresis System. A marvel of medical technology, the system allows our highly skilled team to meet the specific collection criteria required for each procedure, ensuring that our process is characterized by accuracy and efficiency. This collection mechanism brings a new purity, consistency, and reliability to the process—attributes that ultimately benefit patients, clinicians, and laboratory processes.